
Celularity Inc
CELUNasdaqCIK 1752828HealthcareFiscal year ends Dec 31
Reports and events: 186 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-06-2216:36 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-23-030962 |
| 2023-06-2116:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-23-029159 |
| 2023-06-1616:27 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-23-028627 |
| 2023-05-3117:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-025401 |
| 2023-05-2216:29 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-023462 |
| 2023-05-1916:26 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-023264 |
| 2023-05-1616:48 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-23-022503 |
| 2023-05-0109:00 ET | DEF 14A | Proxy statementPeriod 2023-06-14 | 0001193125-23-128936 |
| 2023-04-2717:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-015374 |
| 2023-04-0720:58 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-094337 |
| 2023-03-3117:21 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-011440 |
| 2023-03-2309:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-23-009338 |
| 2023-03-1717:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-008663 |
| 2023-03-1717:17 ET | 8-K | 3.01 Delisting notice | 0000950170-23-008662 |
| 2023-03-1308:56 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-23-007462 |
| 2023-01-3016:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-001378 |
| 2022-12-1608:38 ET | 8-K | 8.01 Other events | 0000950170-22-026638 |
| 2022-11-1016:29 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-024523 |
| 2022-11-1016:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-024493 |
| 2022-10-0616:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-258852 |
| 2022-09-2316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-250130 |
| 2022-09-1516:11 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-22-245623 |
| 2022-09-0808:48 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-240629 |
| 2022-08-1019:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-216404 |
| 2022-08-0916:31 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001564590-22-028775 |
| 2022-07-2016:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-198101 |
| 2022-07-1517:17 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001193125-22-195133 |
| 2022-07-1416:06 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-193761 |
| 2022-06-1716:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-176615 |
| 2022-06-0316:46 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-167406 |
| 2022-06-0316:40 ET | DEF 14A | Proxy statementPeriod 2022-07-13 | 0001193125-22-167393 |
| 2022-05-2521:01 ET | S-1 | Registration statement | 0001193125-22-158801 |
| 2022-05-2016:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-156126 |
| 2022-05-1616:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-151903 |
| 2022-05-1616:39 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001564590-22-020422 |
| 2022-05-1106:09 ET | S-1/A | Registration statement, amended | 0001193125-22-146808 |
| 2022-05-0316:11 ET | 8-K | 8.01 Other events | 0001193125-22-138682 |
| 2022-04-2907:31 ET | S-1 | Registration statement | 0001193125-22-130204 |
| 2022-03-3116:17 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001564590-22-013004 |
| 2022-03-3116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-012992 |
| 2022-03-1616:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-077225 |
| 2022-03-0116:47 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-22-061431 |
| 2022-02-1608:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-044020 |
| 2022-01-1816:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-011229 |
| 2021-12-2816:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-367920 |
| 2021-12-1708:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-360062 |
| 2021-11-1216:38 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-056724 |
| 2021-11-1216:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-056712 |
| 2021-09-1516:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-21-048256 |
| 2021-08-2019:35 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-21-043933 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 02:51 ET. Listed shows no prices and gives no investment advice.